CSTL Q1 2019 Earnings — Castle Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CSTLCastle Biosciences, Inc.

$772M

Q1 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$9M+138.3% YoY

Gross Profit

$7M81.7% margin

Operating Income

-$321,444-3.7% margin

Net Income

-$1M-15.6% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

-23.8%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

$1M

Stock-Based Comp.

$168,421

Balance Sheet

Total Assets

$31M

Total Liabilities

$29M

Stockholders' Equity

$2M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$4M	+138.3%
Gross Profit	$7M	$2M	+195.9%
Operating Income	-$321,444	-$3M	+89.6%
Net Income	-$1M	-$4M	+62.6%